| Andrea Fast, MS, CCC-SLP | |
|
1471 Twilight Trl Ste A, Frankfort, KY 40601-8497 | |
| (606) 776-1450 | |
| Not Available |
| Full Name | Andrea Fast |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1471 Twilight Trl Ste A, Frankfort, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902439318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 138642 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Fast, MS, CCC-SLP 1471 Twilight Trl Ste A, Frankfort, KY 40601-8497 Ph: (606) 776-1450 | Andrea Fast, MS, CCC-SLP 1471 Twilight Trl Ste A, Frankfort, KY 40601-8497 Ph: (606) 776-1450 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
In 2010, Christian humanitarian organization World Vision embarked on a campaign to impact 20 million people in poverty around the world.
University of Illinois scientists report that soy protein may significantly reduce fat accumulation and triglycerides in the livers of obese persons. And they've discovered why it happens: soy restores partial function of that organ's key signaling pathway.
neuMirRx Corp today welcomed the issuance of U.S. patent 7,345,093, entitled "Methods for Enhancing Solubility of Compounds" which covers novel formulation methods to enhance the solubility of hydrophobic compounds.
Over the past months, many potential antivirals against SARS-CoV-2 have been identified as deserving further development to target several viral proteins. A new study deals with one such molecule, the viral main protease (Mpro) inhibitor GC-376, and describes its efficacy in inhibiting virus-host interaction.
› Verified 2 days ago
Emily Bentley, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 66 C Michael Davenport Blvd, Frankfort, KY 40601 Phone: 210-331-8804 | |
Mrs. Sara Elizabeth Pence, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 275 E Main Street Hs2w C, Frankfort, KY 40621 Phone: 502-564-3756 | |
Elizabeth Reed Smither, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1040 Us Highway 127 S, Frankfort, KY 40601 Phone: 502-875-5600 | |
Mrs. Marissa Beth Hillard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 872 Stillhouse Hollow Rd, Frankfort, KY 40601 Phone: 502-229-4842 | |
Mrs. Elizabeth Van Kersen Franzini, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1471 Twilight Trl Ste A, Frankfort, KY 40601 Phone: 606-776-1450 Fax: 502-352-2967 | |
Jenna Sutton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1471 Twilight Trl Ste A, Frankfort, KY 40601 Phone: 606-776-1450 Fax: 502-352-2967 | |
Michele Lynne Zaparanick-brown, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Wood Duck Dr, Frankfort, KY 40601 Phone: 502-226-0087 Fax: 502-695-9120 |